RecruitingNCT04781972
Brain activity before and after methylphenidate in ADHD research
About this title
Read the official source — NCT04781972Medication studyAges 6–40United States
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 6 years to 40 years. Other eligibility criteria apply.
What will I do during this study?
You receive a single dose of methylphenidate and a matching placebo (an inactive comparison treatment) on separate occasions, in an order determined by your group and with a one-week gap. After each treatment, you complete cognitive tests and brain imaging using functional MRI (magnetic resonance imaging) and magnetic resonance spectroscopy.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 27, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 6 Years to 40 Years
- Official registry ID
- NCT04781972
- Official title
Show the full official title
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Does this study involve medication?
Yes. The study involves medication, including Methylphenidate and Placebo.
Who can participate?
This study is for people with ADHD. Listed age limits: 6 years to 40 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
